Attached files
file | filename |
---|---|
8-K - 8-K - SYNERGY PHARMACEUTICALS, INC. | a17-21375_18k.htm |
Synergy Pharmaceuticals to Present at Upcoming September Investment Conferences
NEW YORK, September 6, 2017 Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced that the company will present corporate updates at three upcoming investment conferences in New York City during September:
Rodman & Renshaw 19th Annual Global Investment Conference on Monday, September 11, 2017 at 9:35 a.m. Eastern Time.
2017 Cantor Fitzgerald Global Healthcare Conference on Monday, September 25, 2017 at 10:20 a.m. Eastern Time.
Ladenburg Thalmann 2017 Healthcare Conference on Tuesday, September 26, 2017 at 10:30 a.m. Eastern Time.
A live webcast of the presentations will be accessible through the Investor Relations section of the companys website at www.synergypharma.com. A replay of the webcast will be available on Synergys website for 90 days following each conference.
About Synergy Pharmaceuticals Inc.
Synergy is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies. The company has pioneered discovery, research and development efforts on analogs of uroguanylin, a naturally occurring and endogenous human GI peptide, for the treatment of GI diseases and disorders. Synergys proprietary GI platform includes one commercial product TRULANCE (plecanatide) and a second lead product candidate, dolcanatide. For more information, please visit www.synergypharma.com.
Company Contact:
Synergy Pharmaceuticals Inc.
Gem Hopkins, 212-584-7610
VP, Investor Relations and Corporate Communications
ghopkins@synergypharma.com